Human neutrophil and plasma endopeptidase 24.11: quantification and respective roles in atrial natriuretic peptide hydrolysis
- 1 March 1995
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 25 (3) , 206-212
- https://doi.org/10.1111/j.1365-2362.1995.tb01550.x
Abstract
FLWNAinfo:eu-repo/semantics/publisheKeywords
This publication has 25 references indexed in Scilit:
- Three-dimensional Architecture of Human α2-Macroglobulin Transformed with MethylamineJournal of Molecular Biology, 1993
- Atriopeptin III degradation by endopeptidase 24.11: The Cys-Phe bond is not the preferential cleavage sitePeptides, 1993
- Metabolism of substance P and bradykinin by human neutrophilsBiochemical Pharmacology, 1991
- Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: Role of enkephalinase (EC 3.4.24.11)Neuropeptides, 1990
- Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?Trends in Pharmacological Sciences, 1990
- Endopeptidase-24.11 in human plasma degrades atrial natriuretic factor (ANF) to ANF(99–105/106–126)Peptides, 1989
- Increased serum levels of endopeptidase 24.11 (‘enkephalinase”) in patients with end-stage renal failureLife Sciences, 1988
- Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage.Journal of Clinical Investigation, 1988
- In vivo ‘enkephalinase’ inhibition by acetorphan in human plasma and CSFEuropean Journal of Pharmacology, 1986
- Disappearance of atrial natriuretic factor from circulation in the ratPeptides, 1986